Tomohide Tanaka

Title: The Innovations of Tomohide Tanaka

Introduction

Tomohide Tanaka is a notable inventor based in Ibaraki, Japan. He has made significant contributions to the pharmaceutical field, particularly in the development of stable polymorphs of donepezil hydrochloride. With a total of 4 patents to his name, Tanaka's work has implications for the treatment of Alzheimer's disease.

Latest Patents

Tanaka's latest patents focus on the polymorphs of donepezil hydrochloride and the processes for their production. These polymorphs, specifically 1-benzyl-4-[(5,6-dimethoxy-1-indanon)-2-yl]methylpiperidine hydrochloride, are designed to be stable against heat and humidity, making them suitable for pharmaceutical use. They can be produced industrially and are characterized by distinct peaks in X-ray powder diffraction patterns and absorption peaks in infrared absorption spectra in potassium bromide.

Career Highlights

Tanaka is currently associated with Eisai Company, Limited, where he continues to innovate in the pharmaceutical sector. His work has been instrumental in enhancing the stability and efficacy of medications used in treating cognitive disorders.

Collaborations

Some of his notable coworkers include Akio Imai and Yoshio Tanabe, who have collaborated with him on various projects within the company.

Conclusion

Tomohide Tanaka's contributions to the field of pharmaceuticals through his innovative patents demonstrate his commitment to improving healthcare solutions. His work on donepezil hydrochloride polymorphs is a testament to his expertise and dedication to advancing medical science.